US Patent Issued to Ioulia Tseti, UNI-PHARMA KLEON TSETIS PHARMACEUTICAL LABORATORIES on July 7 for "Method of using L-triiodothyronine (T3) for the treatment of tissue hypoxia and sepsis" (Greek Inventors)

ALEXANDRIA, Va., July 7 -- United States Patent no. 12,673,036, issued on July 7, was assigned to Ioulia Tseti (Attica, Greece) and UNI-PHARMA KLEON TSETIS PHARMACEUTICAL LABORATORIES S.A. (Athens, Greece).

"Method of using L-triiodothyronine (T3) for the treatment of tissue hypoxia and sepsis" was invented by Constantinos Pantos (Kantza Pallini, Greece) and Iordanis Mourouzis (Korydallos, Greece).

According to the abstract* released by the U.S. Patent & Trademark Office: "A method of using a composition consisting of L-triiodothyronine or a pharmaceutically acceptable salt thereof and one or more pharmaceutically acceptable excipients, for the treatment of a patient having an inflammatory response and one or multi-organ dysfunction, incl...